SLENYTO® is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and/or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient.
SLENYTO® is a 3mm diameter film coated mini-tablet that contains the active ingredient, melatonin, a hormone produced naturally by the body.
SLENYTO® is available in two dosage forms – 1 mg prolonged-release melatonin tablets and 5 mg prolonged-release melatonin tablets
SLENYTO® is a prescription-only medicine and should always be used exactly as advised by the doctor or pharmacist.
Presented information is not intended to replace a consultation with a qualified physician. Do not rely on the content and presented information for the purpose of receiving or providing medical care.
Before use, consult the doctor / product information leaflet.
We’re happy to hear what’s on your mind. If you have questions about our products or about professional opportunities with Neurim, please share them with us. One of our representatives will respond to you.